Vellgus Red Light Team

Direct Answer: Currently, there is no clinical evidence supporting the use of red light therapy (photobiomodulation) as a primary treatment for Polymyalgia Rheumatica. PMR is a systemic inflammatory rheumatic disease that requires prompt medical management with glucocorticoids to control inflammation…

Dermatomyositis (DM) is a rare autoimmune condition characterized by muscle weakness and distinctive skin rashes, affecting roughly 5 in every million people . For patients managing chronic symptoms, the search for complementary therapies is understandable. One question that frequently arises…

Bottom line: Red light therapy (photobiomodulation) is not a treatment for polymyositis itself, but emerging evidence suggests it may serve as a supportive adjunct for managing localized muscle pain and promoting tissue recovery. The therapy cannot penetrate deep enough to…

Bottom line: Red light therapy (photobiomodulation) shows biological promise for reducing inflammation and supporting tissue repair, but direct clinical evidence for myositis—particularly dermatomyositis and polymyositis—remains limited. No major rheumatology or neurology guidelines currently recommend red light therapy as a primary…

Key Takeaways Understanding Muscle Atrophy and Photobiomodulation Muscle atrophy—the loss of muscle mass and strength—represents a significant clinical challenge. It arises from diverse causes including immobilization, denervation, aging (sarcopenia), chronic disease, and glucocorticoid therapy. The condition results from an imbalance…

Bottom line: A growing body of clinical research suggests that red light therapy—also called photobiomodulation (PBM) or low-level laser therapy (LLLT)—can be an effective, non-invasive treatment for reducing pain and improving quality of life in people with fibromyalgia. Several randomized…

Quick Answer: Yes—red light therapy, clinically termed photobiomodulation (PBM), has demonstrated effectiveness in reducing pain and improving pressure pain thresholds in myofascial pain syndrome, particularly when combined with exercise. A 2022 systematic review of 944 patients found that PBM plus exercise…

Quick Answer: Red light therapy (photobiomodulation) shows promising evidence for reducing myalgia—muscle pain—particularly exercise-induced muscle soreness and chronic musculoskeletal pain conditions. Clinical studies demonstrate significant reductions in pain scores and inflammatory markers, though optimal treatment protocols continue to be refined. Understanding…

Bottom line: Red light therapy (photobiomodulation) is FDA-cleared for temporary relief of muscle spasms and muscle relaxation, but the evidence base is mixed—stronger for localized musculoskeletal spasm relief than for neurological twitching conditions like hemifacial spasm. This article examines what the clinical literature…

Delayed onset muscle soreness (DOMS) is a familiar challenge for athletes, fitness enthusiasts, and anyone who has pushed their physical limits. Characterized by muscle tenderness, stiffness, and pain that typically peaks 24 to 72 hours after unaccustomed or high-intensity exercise,…